BiomarkersHuman trial

Large-Scale Proteomic Discovery of Prognostic and Treatment-Responsive CKD Biomarkers in SELECT

ADA Scientific Sessions 2026 Abstract

The paper

Petter Bjornstad, Helen M. Colhoun, Katherine R Tuttle,

Steven Kahn, Jan C. Refsgaard, Kristian B. Hessellund, Karolina Sulek, Naveen Rathor, Tobias N. Wistisen, Fernando Palluzzi, Miquel Triana Iglesias, Thomas Idorn, Lotte Bjerre Knudsen,

Vivek Das

Seattle

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 1728-P

doi.org/10.2337/db26-1728-p

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Blood proteins improve early cardiometabolic risk prediction
Diabetes, Obesity & Metabolism · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026